The unethical use of ethical rhetoric: the case of flibanserin and pharmacologisation of female sexual desire
The current debate around sexual dysfunctions focuses mostly on the pharmacological regulation of lowered sexual desire in women. The Food and Drug Administration approval of the first drug—Addyi—to treat this condition was preceded by a campaign, in which ethically saturated arguments were used to...
Authors: | ; |
---|---|
Format: | Electronic Article |
Language: | English |
Check availability: | HBZ Gateway |
Journals Online & Print: | |
Fernleihe: | Fernleihe für die Fachinformationsdienste |
Published: |
BMJ Publ.
2016
|
In: |
Journal of medical ethics
Year: 2016, Volume: 42, Issue: 11, Pages: 701-704 |
Online Access: |
Volltext (JSTOR) Volltext (lizenzpflichtig) Volltext (lizenzpflichtig) |